Part 2: Practical examples in health economic modelling of oncological treatments
08 Nov 2019, 16:00 CET
Webinar

Following Part 1 of the webinar, we will present some of tackled methodological issues through practical examples of cost-effectiveness modelling done and/or published by Mihajlović Health Analytics (MiHA). This will include statistical dealing with the censoring (withdrawal) in an oncological clinical trial, appropriate handling of hazard proportionality, and network meta-analysis of summary survival data using the method of fractional polynomials. 

 

Speaker: Dr Jovan Mihajlović

Jovan Mihajlović is CEO of Mihajlović Health Analytics (MiHA) which he founded in 2013 as a spin-off company to the University of Groningen. Jovan obtained the Master’s degree in pharmacy in 2006, and defended his PhD thesis “Health Economics of Targeted Cancer Therapies“ at the University of Groningen, the Netherlands, in 2016. He focussed his research on methodological aspect of modelling targeted cancer therapies, in particular on survival analysis and simultaneous comparisons through network meta-analysis. Subsequently, he published several studies in renowned journals, was speaker at numerous health economic and oncological professionals’ meetings, regularly exhibited his work at the biggest pharmacoeconomic conferences and was appointed reviewer of several scientific journals. Parallel to his scientific research, through MiHA Jovan was developing health economics consultancy services to the industry and academia. He designed and adjusted cost-effectiveness and budget impact models, conducted epidemiological studies, systematic reviews, network meta-analyses and completed pharmacoeconomic dossiers for more than 70 medicines and medical devices for the industry, academia and other consultancies in the Netherlands, Belgium, the United Kingdom, Slovenia and Serbia.